What if my patented or patent pending invention is developed under a Cooperative Research and Development Agreement (CRADA)?
The CRADA partner has the option for an exclusive license to patented materials developed under a CRADA. If the CRADA partner declines to take an exclusive license, CDC can license the invention to other parties. Who gets the royalties from a license? Both the inventor and the laboratory in which the inventor works are entitled to royalties. See the royalty policy in Chapter V of the Technology Transfer Manual for more details or contact TTO. If you have additional questions, please contact TTO at 770-488-8600 or email at tto@cdc.gov This page contains several links to PDF files which may require a browser plug-in to view correctly. If you do not have the most recent version of Adobe Acrobat Reader, or are having difficulty viewing the PDF, download the plug-in here.
Related Questions
- What if my patented or patent pending invention is developed under a Cooperative Research and Development Agreement (CRADA)?
- What if my EIR describes materials developed under a Cooperative Research and Development Agreement (CRADA)?
- How is a Space Act Agreement different from a Cooperative Research and Development Agreement?